BASIC DIFFERENCES IN HEMODYNAMIC-EFFECTS OF THE CARDIOSELECTIVE BETA-ADRENOBLOCKER ACEBUTOLOL AND NONSELECTIVE BETA-ADRENOBLOCKER PROPRANOLOL IN LONG-TERM ANTIHYPERTENSIVE THERAPY
Vi. Metelitsa et al., BASIC DIFFERENCES IN HEMODYNAMIC-EFFECTS OF THE CARDIOSELECTIVE BETA-ADRENOBLOCKER ACEBUTOLOL AND NONSELECTIVE BETA-ADRENOBLOCKER PROPRANOLOL IN LONG-TERM ANTIHYPERTENSIVE THERAPY, Kardiologia, 33(4), 1993, pp. 32-38
The cardioselective beta-adrenoblocker acebutolol used as a course the
rapy for 12 weeks was found to be a highly beneficial antihypertensive
agent. The antihypertensive effect of the agent given in doses of 400
-800 mg/day was as pronounced and prolonged as that of propranolol, 80
-160 mg/day, though there is a tendency for acebutolol to show its com
plete or partial antihypertensive effect rather at the end of monother
apy than propranol. At the same time the bradycardiac effect was more
pronounced in propranolol therapy. The antihypertensive effect of aceb
utolol, 400-800 mg/day, was revealed after 2 weeks of its use and pers
isted within the entire 12 weeks of therapy. The drug was well tolerat
ed. In contrast to propranolol, a non-selective bea-adrenoblocker havi
ng no intrinsic sympathomimetic activity, acebutolol failed to produce
adverse effects, such as by decreasing cardiac output and increasing
total peripheral vascular resistance. The agent had a less negative ch
ronotropic effect.